Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siplizumab (MEDI-507) in Plaque Psoriasis
NCT00540618Phase 2Completed
- Sponsor
- MedImmune
- Start
- Sep 2001
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of siplizumab in plaque psoriasis, sponsored by MedImmune. Started Sep 2001; status: completed.
02
Drugs
siplizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00540618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540618.